Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.38B |
| 2 |
NVIDIA
NVDA
|
+$732M |
| 3 |
Amazon
AMZN
|
+$606M |
| 4 |
Walt Disney
DIS
|
+$559M |
| 5 |
AT&T
T
|
+$466M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$1.41B |
| 2 |
Comcast
CMCSA
|
+$658M |
| 3 |
Boston Scientific
BSX
|
+$650M |
| 4 |
Palo Alto Networks
PANW
|
+$642M |
| 5 |
T-Mobile US
TMUS
|
+$577M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.81% |
| 2 | Healthcare | 2.95% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.15% |
| 5 | Industrials | 1.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
12501
CALL
Cerus
CERS
$468M
| $20.7K | ﹤0.01% |
9,600
-2,900
| -23% | -$4.78K |
|
12502
AdvisorShares Pure Cannabis ETF
YOLO
$30.2M
| $20.7K | ﹤0.01% |
6,859
-2,600
| -27% | -$7.57K |
|
12503
CALL
Saratoga Investment
SAR
$313M
| $20.7K | ﹤0.01% |
800
-10,700
| -93% | -$267K |
|
12504
CALL
Karyopharm Therapeutics
KPTI
$44.2M
| $20.7K | ﹤0.01% |
1,593
+540
| +51% | +$7.28K |
|
|
ROVR
12505
CALL
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
| $20.7K | ﹤0.01% |
1,900
+900
| +90% | +$7.61K |
|
12506
PUT
Limoneira
LMNR
$249M
| $20.6K | ﹤0.01% |
+1,000
| New | +$16.2K |
|
12507
CALL
Procure Space ETF
UFO
$624M
| $20.5K | ﹤0.01% |
+1,100
| New | +$18K |
|
12508
CALL
Enlivex Ltd
ENLV
$33.3M
| $20.5K | ﹤0.01% |
507
+407
| +407% | +$10.4K |
|
12509
Bridgeline Digital
BLIN
$13.6M
| $20.5K | ﹤0.01% |
23,712
-12,976
| -35% | -$9.98K |
|
|
CHRN
12510
PUT
ChronoScale Holdings
CHRN
$2.94B
| $20.5K | ﹤0.01% |
547
+534
| +4,108% | +$10.1K |
|
12511
CALL
Flotek Industries
FTK
$1.32B
| $20.4K | ﹤0.01% |
5,212
+3,359
| +181% | +$13.1K |
|
12512
CALL
AngioDynamics
ANGO
$625M
| $20.4K | ﹤0.01% |
2,600
+1,900
| +271% | +$13.2K |
|
12513
CALL
MeiraGTx Holdings
MGTX
$1.18B
| $20.4K | ﹤0.01% |
2,900
-11,400
| -80% | -$56.3K |
|
|
MITT
12514
PUT
TPG Mortgage Investment Trust
MITT
$222M
| $20.4K | ﹤0.01% |
3,206
-20,494
| -86% | -$111K |
|
12515
5E Advanced Materials
FEAM
$72.2M
| $20.2K | ﹤0.01% |
+623
| New | +$30.3K |
|
|
BCLI
12516
CALL
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| $20.2K | ﹤0.01% |
4,933
-3,667
| -43% | -$11K |
|
12517
PUT
State Street SPDR Portfolio Europe ETF
SPEU
$739M
| $20.2K | ﹤0.01% |
500
-100
| -17% | -$3.73K |
|
12518
CALL
PMV Pharmaceuticals
PMVP
$62.9M
| $20.1K | ﹤0.01% |
6,500
-7,100
| -52% | -$18.8K |
|
12519
Imunon
IMNN
$6.64M
| $20.1K | ﹤0.01% |
2,271
-1,169
| -34% | -$14.3K |
|
12520
China Pharma Holdings
CPHI
$49M
| $20.1K | ﹤0.01% |
+3,324
| New | +$18.6K |
|
12521
CALL
Westwood Holdings Group
WHG
$185M
| $20.1K | ﹤0.01% |
+1,600
| New | +$16.9K |
|
|
INZY
12522
CALL
DELISTED
Inozyme Pharma
INZY
| $20K | ﹤0.01% |
4,700
-21,000
| -82% | -$74.6K |
|
12523
CALL
Planet Labs
PL
$8.1B
| $20K | ﹤0.01% |
8,100
+7,500
| +1,250% | +$17.7K |
|
|
SLI
12524
PUT
Standard Lithium
SLI
$559M
| $20K | ﹤0.01% |
9,900
+4,300
| +77% | +$10.7K |
|
|
REVG
12525
PUT
DELISTED
REV Group
REVG
| $20K | ﹤0.01% |
1,100
-1,000
| -48% | -$16K |
|
Similar funds
Citadel Advisors's Q4 2023 Portfolio in Review
As of Q4 2023, Citadel Advisors held 15,795 positions worth $500B, up 7.2% from $467B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors withdrew a net $25.4B in Q4 2023, closing 1,625 positions and reducing 6,315 holdings. Its most notable exit was Activision Blizzard, an estimated $1.41B position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, down from 3.9% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Citadel Advisors opened a new position in iShares iBoxx $ Investment Grade Corporate Bond ETF worth $129M.
- Citadel Advisors's largest Q4 2023 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 1,167,658 shares worth $129M.
- Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $1.38B increase.
- Citadel Advisors's biggest Q4 2023 reduction was Comcast, cutting an estimated $658M.
- Citadel Advisors fully exited Activision Blizzard in Q4 2023, selling an estimated $1.41B.
- Citadel Advisors's ten largest holdings make up 31% of its $500B portfolio in Q4 2023.
- Citadel Advisors opened 1,585 new positions and closed 1,625 in Q4 2023.
- Citadel Advisors's portfolio value rose 7.2% quarter-over-quarter to $500B.
Based on Citadel Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.